(NASDAQ: ECOR) Electrocore's forecast annual revenue growth rate of 33.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Electrocore's revenue in 2025 is $25,182,000.On average, 2 Wall Street analysts forecast ECOR's revenue for 2025 to be $226,150,812, with the lowest ECOR revenue forecast at $217,662,964, and the highest ECOR revenue forecast at $234,638,661. On average, 2 Wall Street analysts forecast ECOR's revenue for 2026 to be $338,542,875, with the lowest ECOR revenue forecast at $316,711,841, and the highest ECOR revenue forecast at $360,373,909.
In 2027, ECOR is forecast to generate $424,572,255 in revenue, with the lowest revenue forecast at $380,082,981 and the highest revenue forecast at $469,061,529.